Karen Hodgkin

COO, Chief Operating Officer, Cell Medica

Karen has over 30 years of experience in planning and running clinical trials. After joining Cell Medica in early 2008 to lead the Clinical Operations and Regulatory functions, Karen moved to become Cell Medica’s COO in September 2016.

In the past, Karen has worked for Boehringer Ingelheim (UK), ICN Pharmaceuticals (UK) and British Biotech (UK/US) and as a clinical operations consultant in the US. Her experience spans a range of therapeutic applications and has been acquired whilst running single and multicenter studies globally.